LDN Social Media
Get connected with us on social networks
Paul Battle PA-C - A Novel Approach to Type 1 Diabetes Mellitus (2017 Conference) (LDN, low dose naltrexone)
Type 1 Diabetes Mellitus (T1DM) is a dysregulation of the immune system where TH-1 cells overproduce inflammatory cytokines that kill pancreatic beta cells. Autoimmune antibodies affect T1DM; multiple antibodies mean more severe diseases, and at a younger age. Other autoimmune diseases tend to occur with T1DM eg thyroid, celiac, Addisons; and should be screened for. Vitamin D3 controls 2000 gene actions and can reduce inflammatory cytokines so may also help with T2DM. IL4 and IL10 are low in T1DM. LDN increases IL10. LDN should be researched and considered another tool to reduce the effects of T1DM.